What is the main business of Arta?

The main business activity of Arta focuses on manufacture of pharmaceutical preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on September 16, 2022.

Where is the headquarters located?

The headquarters is located at: Hutnicza 8, 03-791 Warszawa.

What is the share capital?

The share capital of the company is PLN 6,000 (approx. $1,621).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $669,689 in 2024, which is an increase of 100.2% compared to 2023.

Is the company profitable?

No, in 2024 the company was not profitable, reporting a net loss of $1,052,492. For comparison, in 2023 the loss was $551,628, meaning the company increased its loss by 81.2%.

What is the largest operating cost?

The largest operating cost category falls under employee remuneration. This category amounted to $612,806 in 2024, representing 39% of all operating expenses.

ARTAsp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2022-09-16

Share capital

6,000.00 PLN

Registered address

Hutnicza 8, 03-791 Warszawa, Poland

Electronic delivery address

AE:PL-22786-80811-WBSHF-16

Financials

Revenue history (in k)

Filing timeliness

2 of 4 financial statements were filed late (the longest delay 83 days for 2022).

202525/06/2026
202405/06/2025
202318/09/2024
202206/10/2023

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 1.79mMedianUSD 917.74kAverageUSD 25.73m

Net profit

This companyUSD -660.23kMedianUSD 14.44kAverageUSD 2.75m

Operating costs

This companyUSD 2.27mMedianUSD 860.03kAverageUSD 21.34m

Assets

This companyUSD 2.31mMedianUSD 883.09kAverageUSD 31.39m

Industry

Authorized Representatives

Andrzej Mirosław Charewicz – Management Board Member

Tomasz Gomulec – President of the Management Board

Piotr Konop – Attorney-in-fact (sole)

Manner of representation

If the management board is a one-person management board, the company is represented by one member of the management board. If the management board is a multi-member management board, two members of the management board jointly, or a member of the management board together with a commercial proxy, are authorised to represent the company.

Ownership

Owner	Shares	Share value	Stake
Andrzej Mirosław Charewiczage 57	12	$162.07	10%
Tomasz Gomulecage 55	12	$162.07	10%
Tactica Pharmaceuticals sp. z o.o.	96	$1,296.60	80%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2022-10-26.

mBank
74 1140 1081 0000 4798 6900 1003
mBank
31 1140 1081 0000 4798 6900 1001
mBank
04 1140 1081 0000 4798 6900 1002

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
Anpharm Przedsiębiorstwo FarmaceutyczneS.A.	$111,469,394.21	anpharm.pl
Tarchomińskie Zakłady Farmaceutyczne PolfaS.A.	$102,988,448.02	polfa-tarchomin.com.pl
VercoS.A.	$43,577,172.02	verco.com.pl
MedicofarmaS.A.	$8,530,473.72	medicofarma.pl
VitamaS.A.	$4,287,087.38	vitama.pl
Munar PharmaS.A.	$85,649.72	munar.pl
Sanford Biotechsp. z o.o.	$2,586.64	sanfordbiotech.com
Cefeasp. z o.o.	$294.66	cefea.pl
Auxilius PharmaS.A.	$0.83	auxiliuspharma.com
Stg25Branch (foreign co.)	–	glagolica.eu

Change history

Date	Event
2024-04-18	Share capital increase (5,000.00 PLN → 6,000.00 PLN)
2022-09-16	Entered in the register

FAQ

Last updated: 2026-06-25